Singapore markets close in 1 hour 44 minutes

Allarity Therapeutics, Inc. (ALLR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7667+0.0340 (+4.64%)
At close: 04:00PM EDT
0.7600 -0.01 (-0.87%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.83M
Enterprise value 4.71M
Trailing P/E 0.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.35
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.42

Trading information

Stock price history

Beta (5Y monthly) 0.52
52-week change 3-99.77%
S&P500 52-week change 325.59%
52-week high 3366.4000
52-week low 30.7100
50-day moving average 34.5116
200-day moving average 314.3536

Share statistics

Avg vol (3-month) 32.79M
Avg vol (10-day) 313.79M
Shares outstanding 52.39M
Implied shares outstanding 62.39M
Float 8308.66k
% held by insiders 10.00%
% held by institutions 10.12%
Shares short (15 Apr 2024) 4105.06k
Short ratio (15 Apr 2024) 40.08
Short % of float (15 Apr 2024) 45.40%
Short % of shares outstanding (15 Apr 2024) 45.40%
Shares short (prior month 15 Mar 2024) 430.71k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 309 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-81.08%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -17.09M
Net income avi to common (ttm)-20.42M
Diluted EPS (ttm)-205.2000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)222k
Total cash per share (mrq)0.72
Total debt (mrq)1.3M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.14
Book value per share (mrq)-15.26

Cash flow statement

Operating cash flow (ttm)-12.74M
Levered free cash flow (ttm)-5.47M